Xaluritamig plus abiraterone shows promising anti-tumour activity with manageable safety in chemotherapy-naïve mCRPC

miR371 shows promise as a surveillance biomarker for relapse in early-stage germ cell tumours

Yoga improves mood, fatigue, and insomnia in cancer survivors following treatment

Apalutamide plus ADT improves surgical outcomes in high-risk prostate cancer

ASCO 2026: Latest updates in mRCC

Darolutamide shows less cognitive decline than enzalutamide in advanced prostate cancer

Combination therapeutic strategies for aRCC patients with bone metastases

Part 1: Why test?

Part 2: How to get biopsies for testing?

Part 3: Managing testing efficiencies – How to optimise next generation sequencing and HRR testing

Part 4: Clinical decision making - Interpretation of next generation sequencing results

Machine learning models improve prediction of immunotherapy outcomes across multiple cancer types